Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Justyna Krzysztofik & Piotr Ponikowski. (2017) Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure. Expert Review of Clinical Pharmacology 10:5, pages 517-534.
Read now
Read now
John T Parissis, Ioanna Andreadou, Vassiliki Bistola, Ioannis Paraskevaidis, Gerasimos Filippatos & Dimitrios T Kremastinos. (2008) Novel biologic mechanisms of levosimendan and its effect on the failing heart. Expert Opinion on Investigational Drugs 17:8, pages 1143-1150.
Read now
Read now
. (2007) Invited Synopses. Acute Cardiac Care 9:3, pages 134-174.
Read now
Read now
Articles from other publishers (30)
Yaoshi Hu, Zhe Wei, Chaoyong Zhang, Chuanghong Lu & Zhiyu Zeng. (2021) The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis. Scientific Reports 11:1.
Crossref
Crossref
Hasan Korkmaz & Mücahid Yilmaz. (2019) The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure. Archives of Medical Science – Atherosclerotic Diseases 4:1, pages 174-179.
Crossref
Crossref
K.-P. Kresoja, G. Schmidt, B. Kherad, F. Krackhardt, F. Spillmann & C. Tschöpe. (2017) Akute und chronische HerzinsuffizienzAcute and chronic heart failure. Herz 42:7, pages 699-712.
Crossref
Crossref
Ibrahim Aktas, Alper Karakus, Sencer Camci, Hasan Ari, Selma Ari, Ahmet Tutuncu, Mehmet Melek & Tahsin Bozat. (2017) The effect of levosimendan on Tp-e interval, Tp-e/QT ratio, Tp-e/QTc ratio and QRS interval in heart failure patients. The European Research Journal.
Crossref
Crossref
Bojun Gong, Zicheng Li & Philip Ching Yat Wong. (2015) Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. Journal of Cardiothoracic and Vascular Anesthesia 29:6, pages 1415-1425.
Crossref
Crossref
John T. Parissis, John Papadakis, Nikolaos P.E. Kadoglou, Christos Varounis, Panagiotis Psarogiannakopoulos, Penelope Rafouli-Stergiou, Ignatios Ikonomidis, Ioannis Paraskevaidis, Ioanna Dimopoulou, Aikaterini Zerva, Kleante Dima, Maria Anastasiou-Nana & Gerasimos Filippatos. (2013) Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. International Journal of Cardiology 168:4, pages 3609-3612.
Crossref
Crossref
R. Pirracchio. (2012) Shock cardiogeno. EMC - Anestesia-Rianimazione 17:4, pages 1-9.
Crossref
Crossref
R. Pirracchio. (2012) Estado de shock cardiogénico. EMC - Anestesia-Reanimación 38:4, pages 1-10.
Crossref
Crossref
R. Pirracchio. (2012) État de choc cardiogénique. EMC - Anesthésie-Réanimation 9:3, pages 1-9.
Crossref
Crossref
John T Parissis, Pinelopi Rafouli-Stergiou, Vassilios Stasinos, Panagiotis Psarogiannakopoulos & Alexandre Mebazaa. (2010) Inotropes in cardiac patients: update 2011. Current Opinion in Critical Care 16:5, pages 432-441.
Crossref
Crossref
Dimitrios Farmakis, John T. Parissis, Vassiliki Bistola, Ioannis A. Paraskevaidis, Efstathios K. Iliodromitis, Gerasimos Filippatos & Dimitrios T. Kremastinos. (2010) Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. International Journal of Cardiology 139:1, pages 75-79.
Crossref
Crossref
John T. Parissis, Pinelopi Rafouli-Stergiou, Ioannis Paraskevaidis & Alexandre Mebazaa. (2008) Levosimendan: from basic science to clinical practice. Heart Failure Reviews 14:4, pages 265-275.
Crossref
Crossref
Tong Liu, Guangping Li & Gang Xu. (2009) Levosimendan May Prevent Postoperative Atrial Fibrillation Through Anti-inflammatory and Antioxidant Modulation. Journal of Cardiothoracic and Vascular Anesthesia 23:5, pages 757-758.
Crossref
Crossref
J. Douglas Kirk, John T. Parissis & Gerasimos Filippatos. (2009) Pharmacologic Stabilization and Management of Acute Heart Failure Syndromes in the Emergency Department. Heart Failure Clinics 5:1, pages 43-54.
Crossref
Crossref
José L. Pérez Vela, María A. Corres Peiretti, Mercedes Rubio Regidor, Alberto Hernández Tejedor, Emilio Renes Carreño, Primitivo Arribas López, Julián Gutiérrez Rodríguez & Narciso Perales Rodríguez de Viguri. (2008) Utilidad de levosimendán en la disfunción ventricular postoperatoria del injerto en el trasplante cardiaco. Revista Española de Cardiología 61:5, pages 534-539.
Crossref
Crossref
John T. Parissis, Apostolos Karavidas, Vassiliki Bistola, Sophia Arapi, Ioannis A. Paraskevaidis, Dimitrios Farmakis, Dimitrios Korres, Gerasimos Filippatos, Evaggelos Matsakas & Dimitrios T. Kremastinos. (2008) Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis 197:1, pages 278-282.
Crossref
Crossref
Leonardo De Luca, Alexandre Mebazaa, Gerasimos Filippatos, John T. Parissis, Michael Böhm, Adriaan A. Voors, Markku Nieminen, Faiez Zannad, Andrew Rhodes, Ali El-Banayosy, Kenneth Dickstein & Mihai Gheorghiade. (2008) Overview of emerging pharmacologic agents for acute heart failure syndromes. European Journal of Heart Failure 10:2, pages 201-213.
Crossref
Crossref
Alexandre Mebazaa, Mihai Gheorghiade, Ileana L. Piña, Veli-Pekka Harjola, Steven M. Hollenberg, Ferenc Follath, Andrew Rhodes, Patrick Plaisance, Edmond Roland, Markku Nieminen, Michel Komajda, Alexander Parkhomenko, Josep Masip, Faiez Zannad & Gerasimos Filippatos. (2008) Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Critical Care Medicine 36:Suppl, pages S129-S139.
Crossref
Crossref
José L. Pérez Vela, María A. Corres Peiretti, Mercedes Rubio Regidor, Alberto Hernández Tejedor, Emilio Renes Carreño, Primitivo Arribas López, Julián Gutiérrez Rodríguez & Narciso Perales Rodríguez de Viguri. (2008) Levosimendan for Postoperative Ventricular Dysfunction Following Heart Transplantation. Revista Española de Cardiología (English Edition) 61:5, pages 534-539.
Crossref
Crossref
John T. Parissis, Ioanna Andreadou, Sophia L. Markantonis, Vasiliki Bistola, Asimina Louka, Anastasia Pyriochou, Ioannis Paraskevaidis, Gerasimos Filippatos, Efstathios K. Iliodromitis & Dimitrios Th. Kremastinos. (2007) Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. Atherosclerosis 195:2, pages e210-e215.
Crossref
Crossref
John T. Parissis, Constantinos Papadopoulos, Maria Nikolaou, Vassiliki Bistola, Dimitrios Farmakis, Ioannis Paraskevaidis, Gerasimos Filippatos & Dimitrios Kremastinos. (2007) Effects of Levosimendan on Quality of Life and Emotional Stress in Advanced Heart Failure Patients. Cardiovascular Drugs and Therapy 21:4, pages 263-268.
Crossref
Crossref
Sophie Mavrogeni, Gregory Giamouzis, Evangelia Papadopoulou, Sophia Thomopoulou, Athanasios Dritsas, George Athanasopoulos, Elias Adreanides, Ioannis Vassiliadis, Konstantinos Spargias, Dimosthenis Panagiotakos & Dennis V. Cokkinos. (2007) A 6-Month Follow-up of Intermittent Levosimendan Administration Effect on Systolic Function, Specific Activity Questionnaire, and Arrhythmia in Advanced Heart Failure. Journal of Cardiac Failure 13:7, pages 556-559.
Crossref
Crossref
Pere Llorens-Soriano, José Carbajosa-Dalmau, José Fernández-Cañadas, José Murcia-Zaragoza, Vicente Climent-Payá, Fadoua Laghzaoui, Santiago Diéguez-Zaragoza & Rafael Carrasco-Moreno. (2007) Experiencia clínica con levosimendán en un servicio de urgencias de un hospital de tercer nivel. Revista Española de Cardiología 60:8, pages 878-882.
Crossref
Crossref
John T. Parissis, Dimitrios Farmakis, Ioannis Praskevaidis, Vassiliki Bistola, Gerasimos Filippatos & Dimitrios T. Kremastinos. (2007) Reply. The American Journal of Cardiology 100:4, pages 742-743.
Crossref
Crossref
John T. Parissis, Dimitrios Farmakis & Markku Nieminen. (2007) Classical inotropes and new cardiac enhancers. Heart Failure Reviews 12:2, pages 149-156.
Crossref
Crossref
John T. Parissis, Dimitrios Farmakis, Vassiliki Bistola, Stamatios Adamopoulos & Dimitrios Th. Kremastinos. (2007) Levosimendan for the Treatment of Acute Heart Failure Syndromes: Time to Identify Subpopulations of Responding Patients. The American Journal of Cardiology 99:1, pages 146-147.
Crossref
Crossref
Pere Llorens-Soriano, José Carbajosa-Dalmau, José Fernández-Cañadas, José Murcia-Zaragoza, Vicente Climent-Payá, Fadoua Laghzaoui, Santiago Diéguez-Zaragoza & Rafael Carrasco-Moreno. (2007) Clinical Experience With Levosimendan in the Emergency Department of a Tertiary Care Hospital. Revista Española de Cardiología (English Edition) 60:8, pages 878-882.
Crossref
Crossref
John T. Parissis, Ioannis Paraskevaidis, Vasiliki Bistola, Dimitrios Farmakis, Fotios Panou, Kallirrhoe Kourea, Maria Nikolaou, Gerasimos Filippatos & Dimitrios Kremastinos. (2006) Effects of Levosimendan on Right Ventricular Function in Patients With Advanced Heart Failure. The American Journal of Cardiology 98:11, pages 1489-1492.
Crossref
Crossref
Juan F. Delgado. (2006) Levosimendán en la insuficiencia cardiaca aguda: pasado, presente y futuro. Revista Española de Cardiología 59:4, pages 309-312.
Crossref
Crossref
Juan F. Delgado. (2006) Levosimendan in Acute Heart Failure: Past, Present, and Future. Revista Española de Cardiología (English Edition) 59:4, pages 309-312.
Crossref
Crossref